Huadong Medicine (HD Medicine)

Update in progress

000963.SZ (Shenzhen)

Company RatingNeutral
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic

Huadong Medicine Co., Ltd. and its subsidiaries wholesale and retail pharmaceutical products in China and internationally. It operates in four segments: Pharmaceutical Industry, Pharmaceutical Business, Aesthetic Medicine, and Industrial Microbiology. The company distributes Chinese and Western medicines, herbal medicines, medical instruments, and a wide range of drugs, plus medical aesthetics products and equipment. It also manufactures antibiotics, Chinese patent medicines, synthetic and genetic engineering drugs, and provides logistics, leasing, and warehousing services. It develops SNK-2726 siRNA and AGT for hypertension. Founded 1993, headquartered in Hangzhou.

Company score

Sentiment: 0.06; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.09; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.00; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.03; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.05; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive